FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4372211000001107: Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2888821000001119 Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2888841000001112 Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Is a Ranitidine 75mg effervescent tablets sugar free 24 tablet true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Is pack of Zantac 75 Dissolve tablets (Haleon UK Ltd) false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has manufactured dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has AMP Zantac 75 Dissolve tablets (Haleon UK Ltd) true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 75 Dissolve tablets (Haleon UK Ltd) 24 tablet 2 x 12 tablets Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start